26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Cancer in the News

Feature Articles

Targeting melanoma cells with a drug-infused graphene matrix

Dr Livia Sima of the Institute of Biochemistry of the Romanian Academy and Dr Emanuel Axente of the National Institute for Laser, Plasma, and Radiation Physics in Romania are developing novel platforms for screening of therapeutic drug combinations for patients with metastatic melanoma.


Posted in Melanoma News, Health Professionals, Of Interest

A Cure In Sight, in partnership with the UCSF Ocular Oncology Center and NORD, Launches Landmark Ocular Melanoma Natural History Study

Cleveland, OH, September 28, 2020—A Cure in Sight and the National Organization for Rare Disorders have launched an innovative study to research ocular melanoma, a disease that can cause blindness, loss of the eye and even death from spread to other organs.


Posted in Melanoma News, Health Professionals, Of Interest

Dr. Eggermont on the Rationale for Evaluating Adjuvant Pembrolizumab in Advanced Melanoma

Alexander M. M. Eggermont, MD, PhD, professor of oncology, University of Paris-Sud, professor of oncological surgery, chair, International Research Network on Cancer, Erasmus University of Rotterdam, Joseph Maisin Honorary Chair of Oncological Surgery, Louvain Catholic University, discusses the rationale for the phase 3 EORTC 1325/KEYNOTE-054 trial, ?evaluating adjuvant pembrolizumab (Keytruda) versus placebo, in advanced melanoma.


Posted in Melanoma News, Health Professionals, Video Reports

Researchers Keep Cancer Cells Out by Blocking the Gate to the Nucleus

The nucleus of a cell is centrally important to an organism. It stores and organizes genetic information, while separating and protecting this very important information from the host of other cellular components.


Posted in Melanoma News, Health Professionals, Of Interest